Understanding HPV and cervical screening. (2nd January 2022)

• Record Type: Journal Article
• Authors: Butler, Sarah; Wilkinson, Yvonne
• Is Part Of: Practice nursing. Volume 33:Number 1(2022)
• Page Start: 14
• Page End: 17
• Publication Date: 2022-01-02
• Subjects: Cervical cancer -- Human papillomavirus infections -- Public health -- Vaccination; Nursing -- Practice -- Great Britain -- Periodicals; 610.730941
• DOI: 10.12968/pnur.2022.33.1.14
• Languages: English
• ISSNs: 0964-9271

Abstract

Abstract : Cervical cancer is preventable and curable. Sarah Butler and Yvonne Wilkinson explain how the cervical screening programme has changed from a cytology based test to HPV primary screening Screening for human papillomavirus is now the primary test for cervical screening in England, Wales and Scotland. Cervical screening for those individuals with a cervix routinely occurs every 3 years for those aged 25–49 (24½ in England) and every 5 years for those aged 50–64. Over 99.7% of cervical cancers are caused by human papillomavirus. Cervical cancer is preventable and curable; primary HPV screening can detect early changes in cervical cells allowing for effective monitoring and treatment.